Literature DB >> 8292608

Role of tyrosine 143 in lactate dehydrogenation by flavocytochrome b2. Primary kinetic isotope effect studies with a phenylalanine mutant.

N Rouvière-Fourmy1, C Capeillère-Blandin, F Lederer.   

Abstract

Flavocytochrome b2 catalyzes the oxidation of lactate at the expense of cytochrome c. After flavin (FMN) reduction by the substrate, reducing equivalents are transferred one by one to heme b2, and from there on to cytochrome c. The crystal structure of the enzyme is known at 2.4-A resolution, and specific roles in catalysis have been assigned to active side chains. Tyr143 in particular, located at the interface between the flavodehydrogenase moiety and the heme-binding domain, was thought to take part in substrate binding, as well as to orient the heme-binding domain for efficient electron transfer. A first study of the properties of a Tyr143Phe mutant showed that the major effect of the mutation was to decrease the rate of electron transfer from flavin to heme [Miles, C.S., Rouvière-Fourmy, N., Lederer, F., Mathews, F.S., Reid, G.A., Black, M.T., & Chapman, S.K. (1992) Biochem. J. 285, 187-192]. In the present paper, we focus on the effect of the mutation on catalysis of lactate dehydrogenation. We report the deuterium kinetic isotope effects on flavin reduction as measured with stopped-flow methods and on cytochrome c reduction in the steady-state using L-[2-2H]lactate. For the wild-type enzyme, isotope effects on FMN reduction, D(kredF) and D(kredF)/Km), were 7.2 +/- 0.9 and 4.2 +/- 1.3, respectively, and for the Y143F mutant values of 4.4 +/- 0.5 and 3.9 +/- 1.1 were obtained. Calculations, from deuterium isotope effects, of substrate Kd values, combined with knowledge of kcat/Km values, lead to the conclusion that Tyr143 does stabilize the Michaelis complex by hydrogen bonding to a substrate carboxylate, as was postulated; but the mutation does not destabilize the transition state more than the Michaelis complex.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8292608     DOI: 10.1021/bi00169a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

Review 1.  Another look at the interaction between mitochondrial cytochrome c and flavocytochrome b (2).

Authors:  Florence Lederer
Journal:  Eur Biophys J       Date:  2011-04-19       Impact factor: 1.733

2.  About the pKa of the active-site histidine in flavocytochrome b2 (yeast L-lactate dehydrogenase).

Authors:  K S Rao; F Lederer
Journal:  Protein Sci       Date:  1998-07       Impact factor: 6.725

3.  Active site and loop 4 movements within human glycolate oxidase: implications for substrate specificity and drug design.

Authors:  Michael S Murray; Ross P Holmes; W Todd Lowther
Journal:  Biochemistry       Date:  2008-01-24       Impact factor: 3.162

4.  Mechanistic and structural studies of H373Q flavocytochrome b2: effects of mutating the active site base.

Authors:  Chi-Lin Tsai; Kuppan Gokulan; Pablo Sobrado; James C Sacchettini; Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2007-06-12       Impact factor: 3.162

5.  On the lack of coordination between protein folding and flavin insertion in Escherichia coli for flavocytochrome b2 mutant forms Y254L and D282N.

Authors:  M Gondry; K H Diêp Lê; F D Manson; S K Chapman; F S Mathews; G A Reid; F Lederer
Journal:  Protein Sci       Date:  1995-05       Impact factor: 6.725

6.  Solvent and primary deuterium isotope effects show that lactate CH and OH bond cleavages are concerted in Y254F flavocytochrome b2, consistent with a hydride transfer mechanism.

Authors:  Pablo Sobrado; Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2003-12-30       Impact factor: 3.162

7.  Conformational flexibility related to enzyme activity: evidence for a dynamic active-site gatekeeper function of Tyr(215) in Aerococcus viridans lactate oxidase.

Authors:  Thomas Stoisser; Michael Brunsteiner; David K Wilson; Bernd Nidetzky
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.